Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age

被引:15
作者
Chen, Yen-Chih [1 ]
Chen, San-Ni [1 ,2 ,3 ]
Yang, Benjamin Chi-Lan [4 ]
Lee, Kun-Hsien [1 ]
Chuang, Chih-Chun [1 ]
Cheng, Chieh-Yin [1 ]
机构
[1] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] DaYeh Univ, Dept Optometry, Changhua, Taiwan
[4] Natl Taiwan Univ, Sch Med, Taipei, Taiwan
关键词
ENDOTHELIAL GROWTH-FACTOR; THRESHOLD RETINOPATHY; OPTICAL-COMPONENTS; LASER TREATMENT; RECURRENCE; CHILDREN; ERROR;
D O I
10.1155/2018/4565216
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To compare refractive and biometric outcomes in patients with type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab (IVR) versus bevacizumab (IVB), at a corrected age of 3 years. Methods. A retrospective case series compared cycloplegic refractive statuses and biometric statuses in patients who received either IVR or IVB for type 1 ROP, from April 2011 to April 2014. Results. A total of 62 eyes (33 patients) with type 1 ROP were evaluated (26 eyes in 13 IVR patients and 36 eyes in 20 IVB patients). There were no differences in birth statuses including gestational age and birth body weight between the two groups. The prevalence of refractive error greater than 1D was higher in the IVB group (p = 0 03), and there was a higher prevalence of high myopia (<-5.0 D, p = 0 03) in the IVB group. Comparisons in biometric finding showed that IVB patients had shallower anterior chamber depth (p = 0 01). Conclusion. Both IVR and IVB showed low refractive errors, even followed at the corrected age of 3 years. No difference was noted between the two groups in refractive statuses. However, IVB was associated with shallower anterior chamber and higher prevalence of refractive error at the corrected age of 3 years.
引用
收藏
页数:6
相关论文
共 23 条
[1]   Diode laser treatment of retinopathy of prematurity - Anatomical and refractive outcomes [J].
Axer-Siegel, Ruth ;
Maharshak, Idit ;
Snir, Moshe ;
Friling, Ronit ;
Ehrlich, Rita ;
Sherf, Ilana ;
Shalev, Benjamin ;
Sirota, Lea ;
Weinberger, Dov .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (06) :839-846
[2]   Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy [J].
Chan, Joyce J. T. ;
Lam, Carol P. S. ;
Kwok, Madeline K. M. ;
Wong, Raymond L. M. ;
Lee, Gary K. Y. ;
Lau, Winnie W. Y. ;
Yam, Jason C. S. .
SCIENTIFIC REPORTS, 2016, 6
[3]   INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY Comparison Between Ranibizumab and Bevacizumab [J].
Chen, San-Ni ;
Lian, Iebin ;
Hwang, Ya-Chi ;
Chen, Yi-Hsing ;
Chang, Yao-Chung ;
Lee, Kun-Hsien ;
Chuang, Chih-Chun ;
Wu, Wei-Chi .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (04) :667-674
[4]   Long-term Evaluation of Refractive Status and Optical Components in Eyes of Children Born Prematurely [J].
Chen, Ta-Ching ;
Tsai, Tzu-Hsun ;
Shih, Yung-Feng ;
Yeh, Po-Ting ;
Yang, Chang-Hao ;
Hu, Fu-Chang ;
Lin, Luke Long-Kuang ;
Yang, Chung-May .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (12) :6140-6148
[5]   Nonresponse and Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Treatment [J].
Chuluunbat, Tsengelmaa ;
Chan, R. V. Paul ;
Wang, Nan-Kai ;
Lien, Reyin ;
Chen, Yen-Po ;
Chao, An-Ning ;
Chen, Kuan-Jen ;
Chen, Tun-Lu ;
Hwang, Yih-Shiou ;
Lai, Chi-Chun ;
Wu, Wei-Chi .
OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (12) :1095-1105
[6]   A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years - Part 2. Refractive outcome [J].
Connolly, BP ;
Ng, EYJ ;
McNamara, JA ;
Regillo, CD ;
Vander, JF ;
Tasman, W .
OPHTHALMOLOGY, 2002, 109 (05) :936-941
[7]   Structural Sequelae and Refractive Outcome After Successful Laser Treatment for Threshold Retinopathy of Prematurity [J].
Dhawan, Anuradha ;
Dogra, Mangat ;
Vinekar, Anand ;
Gupta, Amod ;
Dutta, Saurabh .
JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2008, 45 (06) :356-361
[8]   Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity [J].
Erol, Muhammet Kazim ;
Coban, Deniz Turgut ;
Sari, Esin Sogutlu ;
Bilgin, Ahmet Burak ;
Dogan, Berna ;
Ozdemir, Ozdemir ;
Tunay, Zuhal Ozen .
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2015, 78 (06) :340-343
[9]   Myopia of prematurity: Nature, nurture, or disease? [J].
Fielder, AR ;
Quinn, GE .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (01) :2-3
[10]  
Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233